Search results for "Induction"

showing 10 items of 769 documents

Rituximab in refractory pemphigus vulgaris

2008

Pemphigus vulgaris (PV) is a severe chronic autoimmune blistering disease of skin and mucous membranes. The use of systemic corticosteroids in pemphigus has dramatically reduced its mortality rate, but the long-term use of steroids leads to severe side effects, many of which are serious. For this reason it is often necessary to add immunosuppressive agents to the regimen. However, there are occasional refractory cases in which therapy with conventionally accepted modalities is either not efficacious or not possible on account of side effects. Rituximab is a therapeutic monoclonal antibody targeting CD20, an integral membrane protein highly expressed on the surface of pre-B lymphocytes and a…

Adultmedicine.medical_specialtyAntigens CD19B-Lymphocyte SubsetsDrug ResistanceDermatologyDrug Administration ScheduleAntibodies Monoclonal Murine-DerivedPharmacotherapyRefractoryRituximab pemphigus vulgarisimmune system diseasesHumansImmunologic FactorsMedicineInfusions IntravenousCD20integumentary systembiologybusiness.industryRemission InductionPemphigus vulgarisAntibodies MonoclonalGeneral MedicineAntigens CD20medicine.diseaseDermatologyRegimenPemphigusMonoclonalImmunologybiology.proteinPrednisoneDrug Therapy CombinationFemaleRituximabRituximabbusinessImmunosuppressive AgentsPemphigusmedicine.drugDermatologic Therapy
researchProduct

Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics anal…

2011

Elevated serum progesterone levels at the end of the follicular phase in controlled ovarian stimulation (COS) leads to a poorer ongoing pregnancy rate in IVF cycles due to reduced endometrial receptivity. The objective of this study was to use microarray technology to compare endometrial gene expression profiles at the window of implantation according to the levels of circulating progesterone.For this prospective cohort study, microarray data were obtained from endometrial biopsies from 12 young healthy oocyte donors undergoing COS with pituitary suppression by either gonadotrophin-releasing hormone (GnRH) agonists or antagonists, and recombinant FSH. On the day of recombinant chorionic gon…

Adultmedicine.medical_specialtyBiologyEndometriumAndrologyEndometriumImmune systemOvulation InductionPregnancyInternal medicineProgesterone receptorGene expressionFollicular phasemedicineHumansEmbryo ImplantationProspective StudiesCell adhesionGeneProgesteroneOligonucleotide Array Sequence Analysisbusiness.industryGene Expression ProfilingRehabilitationObstetrics and GynecologyGeneral MedicineGenomicsGene expression profilingPregnancy rateEndocrinologymedicine.anatomical_structureFollicular PhaseGene Expression RegulationReproductive MedicineFemaleEndometrial receptivitybusinessFunctional genomicsHuman Reproduction
researchProduct

Inter-cycle and inter-observer variability of the antral follicle count in routine clinical practice

2017

Antral follicle count (AFC) is a reliable predictor of ovarian response to stimulation and its inter-cycle and inter-observer variability has been extensively studied on in vitro fertilization (IVF), mostly in highly selected populations within studies not originally designed for this purpose. In this retrospective cohort study, we assess the inter-cycle variation of AFC in a setting similar to that of the daily practice. We included only patients undergoing mild stimulation for intrauterine insemination (IUI). One hundred and forty-eight patients had two (62 patients, group A), three (49 patients, group B) or four (37 patients, group C) IUI cycles and AFC was measured on early follicular p…

Adultmedicine.medical_specialtyEndocrinology Diabetes and MetabolismConcordancemedicine.medical_treatmentCell Count030209 endocrinology & metabolismGroup BYoung Adult03 medical and health sciences0302 clinical medicineEndocrinologyOvarian FollicleOvulation InductionInternal medicinemedicineHumansRoutine clinical practiceOvarian ReserveOvarian reserveInsemination ArtificialMenstrual CycleRetrospective StudiesUltrasonographyObserver VariationGynecology030219 obstetrics & reproductive medicineIn vitro fertilisationbusiness.industryObstetrics and GynecologyRetrospective cohort studyAntral follicleFemalebusinessObserver variationGynecological Endocrinology
researchProduct

Prospective Parallel Randomized, Double-Blind, Double-Dummy Controlled Clinical Trial Comparing Clomiphene Citrate and Metformin as the First-Line Tr…

2005

Abstract Context: Although metformin has been shown to be effective in the treatment of anovulation in women with polycystic ovary syndrome (PCOS), clomiphene citrate (CC) is still considered to be the first-line drug to induce ovulation in these patients. Objective: The goal of this study was to compare the effectiveness of metformin and CC administration as a first-line treatment in anovulatory women with PCOS. Design: We describe a prospective parallel randomized, double-blind, double-dummy controlled clinical trial. Setting: The study was conducted at the University “Magna Graecia” of Catanzaro, Catanzaro, Italy. Patients: One hundred nonobese primary infertile anovulatory women with PC…

Adultmedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentClinical BiochemistryWEIGHT-LOSSIMPROVEMENTContext (language use)PLACEBO-CONTROLLED TRIALPlaceboTHERAPYBiochemistrylaw.inventionAnovulationEndocrinologyDouble-Blind MethodOvulation InductionRandomized controlled trialClomifenelawinsulin resistanceInternal medicinePCOSmedicineHumansCRITERIAclomipheneProspective StudiesPolycystic ovary syndromeGynecologybusiness.industryBiochemistry (medical)medicine.diseasePolycystic ovarymetformineMetforminPREGNANCYEndocrinologyPCOS; metformine; clomipheneovulationFemaleOvulation inductionGLUCOSE-TOLERANCEclomifenemetforminbusinessOBESE WOMENAnovulationmedicine.drugThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Clinical comparison of extracorporeal piezoelectric lithotripsy (EPL) and intracorporeal electrohydraulic lithotripsy (EHL) in difficult bile duct st…

1995

Today, nearly 90% of common bile duct stones are extracted endoscopically. Problems are encountered if there are large stones or a duct stenosis. Extracorporeal piezoelectric lithotripsy (EPL) as well as intracorporeal electrohydraulic lithotripsy (EHL) serve as an alternative to surgical intervention for those few patients in whom endoscopic measures have failed. A total of 35 patients with common bile duct stones in whom conventional endoscopic treatment had failed were selected on the condition that stone visualization through ultrasound was possible and that the papilla was within easy reach of the endoscope. Patients fulfilling the inclusion criteria were randomly treated either by EPL…

Adultmedicine.medical_specialtyPhysiologymedicine.medical_treatmentGallstonesLithotripsyExtracorporealLithotripsymedicineHumansProspective StudiesTreatment FailureAgedAged 80 and overCommon bile ductBile ductbusiness.industryRemission InductionGastroenterologyMiddle AgedExtracorporeal shock wave lithotripsyLaser lithotripsySurgeryMajor duodenal papillamedicine.anatomical_structureBiliary tractbusinessDigestive diseases and sciences
researchProduct

Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 400…

2010

background: The influence of elevated serum progesterone levels during in vitro fertilization/intracytoplasmic sperm injection (IVF/ ICSI) cycles on pregnancy rates is a matter of continued debate among fertility clinicians. Efforts to resolve this question have been impeded by the various assays used to measure progesterone and the different, arbitrary threshold values for defining ‘high’ progesterone levels. methods: A non-interventional, retrospective, observational, single-centre cohort study evaluated the relationship between serum progesterone levels on the day of human chorionic gonadotrophin (hCG) administration and the ongoing pregnancy rate in 4032 patients undergoing IVF/ICSI cyc…

Adultmedicine.medical_specialtyPregnancy Ratemedicine.drug_classmedia_common.quotation_subjectmedicine.medical_treatmentFertilityStimulationFertilization in VitroGonadotropin-releasing hormoneBiologyChorionic GonadotropinIntracytoplasmic sperm injectionCohort StudiesGonadotropin-Releasing HormoneAndrologyOvulation InductionPregnancyInternal medicinemedicineHumansProgesteroneRetrospective Studiesmedia_commonPregnancyIn vitro fertilisationbusiness.industryRehabilitationObstetrics and GynecologyGeneral MedicineOdds ratioMiddle Agedmedicine.diseaseConfidence intervalPregnancy rateEndocrinologyReproductive MedicineRegression AnalysisReproductive Control AgentsGestationFemaleOvulation inductionFollicle Stimulating HormoneGonadotropinbusinesshormones hormone substitutes and hormone antagonistsHormoneHuman Reproduction
researchProduct

Data comparison between pharmacological induction of labour and spontaneous delivery. A single centre experience.

2016

Objectives: To assess the differences in the maternal and fetal outcomes between pharmacological induced and sponta­neous labour in nulliparous women. Material and methods: Observational cohort study carried out over a period of 2 years. Inclusion criteria: nulliparous sin­gleton pregnancies, with cephalic fetal presentation, elective labour induction with intra-vaginal prostaglandin E2 (PGE2) gel (Prepidil® 2 mg) at a gestational age of 41 weeks. Control group: patients who entered labour spontaneously at a gestational age of ≥ 40 weeks. The main demographic maternal characteristics and intra- and postpartum data were extracted from computer records and obstetrics diaries and were used for…

Adultmedicine.medical_specialtyTime FactorsProstaglandin E2Cohort Studies03 medical and health sciences0302 clinical medicineObstetrics and gynaecologyPregnancy030225 pediatricsSpontaneous labourOxytocicsInduction of labourMedicineInduction of labour Neonatal outcome Prostaglandin E2 Spontaneous labour Medicine (all) Obstetrics and GynecologyHumans030212 general & internal medicineLabor InducedProstaglandin E2reproductive and urinary physiologyGynecologyFetusbusiness.industryObstetricsInfant NewbornPregnancy OutcomeObstetrics and GynecologyGestational ageSpontaneous labourFetal PresentationNeonatal outcomeDelivery ObstetricSingle centreProstaglandinsFemalebusinessCohort studymedicine.drugGinekologia polska
researchProduct

Hormonal and molecular characterization of follicular fluid, cumulus cells and oocytes from pre-ovulatory follicles in stimulated and unstimulated cy…

2012

background: The use of ovarian stimulation, to stimulate a multi-follicular response for assisted reproduction treatments, may force the production of oocytes from follicles that do not reach optimal maturation, possibly yielding oocytes that are not fully competent. The present study aimed to define the follicular environment and oocyte competence of unstimulated pre-ovulatory follicles, to compare it with that of similar-sized stimulated follicles. For this purpose, we analyzed the follicular hormonal milieu, the oocyte meiotic spindle, the embryo development and the cumulus cells gene expression (GE) profiles. methods and results: The study population was divided in two groups: (i) 42 oo…

Adultmedicine.medical_specialtymedia_common.quotation_subjectGene ExpressionBiologyOvarian FollicleOvulation InductionInternal medicineFollicular phasemedicineHumansTestosteroneRNA MessengerSperm Injections IntracytoplasmicOvarian follicleOvulationProgesteronemedia_commonCumulus CellsEstradiolReverse Transcriptase Polymerase Chain ReactionRehabilitationAndrostenedioneObstetrics and GynecologyEmbryoLuteinizing HormoneEmbryo MammalianMicroarray AnalysisOocyteFollicular fluidCumulus oophorusHormonesFollicular FluidMeiosismedicine.anatomical_structureEndocrinologyReproductive MedicineOocytesFemaleFolliculogenesisFollicle Stimulating HormoneHuman Reproduction
researchProduct

The follicular hormonal profile in low-responder patients undergoing unstimulated cycles: is it hypoandrogenic?

2012

STUDY QUESTION What is the final hormonal milieu of pre-ovulatory follicles of low-responder (LR) patients undergoing unstimulated cycles? SUMMARY ANSWER Neither androgen secretion nor LH was impaired in pre-ovulatory follicles of LR women. WHAT IS KNOWN ALREADY Therapies currently used to improve ovarian response in LR women have an impact on the final hormonal follicular milieu, and these changes are believed to be partially responsible for determining the success rate in these women. Surprisingly, as far as we know, there is no report of the final hormonal profile of LR women undergoing unstimulated cycles or evidence that follicular androgen secretion in LR women is impaired. STUDY DESI…

Adultmedicine.medical_specialtymedicine.drug_classDrug ResistanceFertilization in VitroSpindle ApparatusBiologyOvarian FollicleOvulation InductionInternal medicineFollicular phasemedicineHumansProspective StudiesOvarian follicleTestosterone CongenersMetaphaseProgesteroneTestosteroneOocyte DonationRehabilitationAge FactorsObstetrics and GynecologyFertility Agents FemaleLuteinizing HormoneAntral follicleAndrogenFollicular fluidFollicular FluidAndrogen secretionEndocrinologymedicine.anatomical_structureFollicular PhaseReproductive MedicineCase-Control StudiesOocytesFemaleFollicle Stimulating HormoneInfertility FemaleHormoneHuman Reproduction
researchProduct

Influence of the ovary on parameters of LH secretion during the recovery from buserelin-induced desensitization

1994

Abstract This study examined the effect of the ovary on LH pulsatility and on the secretory performance of gonadotrophes during the phase of recovery after treatment with buserelin, a GnRH analogue. We included 12 patients, who received buserelin (1.2 mg/day, intranasally for 3 months) as a reductive therapy for uterine leiomyomatosis prior to hysterectomy. Six patients were oophorectomized and the other 6 patients had their ovaries preserved. LH was measured in samples taken basally up to 36 days after suppression of buserelin. LH pulsatility was studied on day 9 along a 24-h cycle, and the response of the hormone to a double-stimulus GnRH test on days 0, 9, 20, and 34. The concentration o…

Adultmedicine.medical_specialtymedicine.drug_classOvariectomymedicine.medical_treatmentRadioimmunoassayUterusEndogenyHysterectomyBuserelinLeiomyomatosisInternal medicinemedicineHumansAdministration IntranasalHysterectomybusiness.industryOvaryRemission InductionObstetrics and GynecologyOophorectomyLuteinizing HormoneMiddle AgedBuserelinEndocrinologymedicine.anatomical_structurePremenopauseReproductive MedicineIn uteroUterine NeoplasmsFemaleGonadotropinbusinessmedicine.drugHormoneEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
researchProduct